ACAM-3000

N/A

Report date: 2022/08/29 20:00:24

Base Information

Drug NameACAM-3000
Drug Alias NameMVA smallpox vaccine - AcambisACAM 3000 MVAMVA 3000ACAM-3000
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDermatitis, AtopicSmallpoxHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAcambisBaxter International Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi PasteurNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsDermatitis, AtopicSmallpoxHIV Infections

Other Information

ATC CodeN/A
Related LinksWikipedia